Metraipolis › archive › dc_d0926f66ee83

Edoxaban for stroke prevention in Chinese patients with atrial fibrillation: 1-year follow-up of the ETNA-AF-China study — Europe PMC PMID:41660516

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41660516
DOI
10.3389/fphar.2026.1739246
License (as archived)
solo-consultazione
Archived
2026-11-06T13:44:09.520Z
SHA-256 of the archived text
78b09216840d4423ac9ba5d7176f81bff5b5cfcb0c95b7dd06cdee97be4200a8
Stable URL of this page
https://metraipolis.com/documento/dc_d0926f66ee83

How to cite

Edoxaban for stroke prevention in Chinese patients with atrial fibrillation: 1-year follow-up of the ETNA-AF-China study — Europe PMC PMID:41660516 — Europe PMC (en), https://europepmc.org/article/MED/41660516 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d0926f66ee83 (Metraipolis archive dc_d0926f66ee83, sha256 78b09216840d4423ac9ba5d7176f81bff5b5cfcb0c95b7dd06cdee97be4200a8)
BibTeX
@misc{dcd0926f66ee83,
  title = {Edoxaban for stroke prevention in Chinese patients with atrial fibrillation: 1-year follow-up of the ETNA-AF-China study — Europe PMC PMID:41660516},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41660516},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d0926f66ee83; sha256 78b09216840d4423ac9ba5d7176f81bff5b5cfcb0c95b7dd06cdee97be4200a8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41660516. Agents can read the archived copy with the MCP tool read_document.